Trials / Completed
CompletedNCT02921399
Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection for Gastric Neoplasm
Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 149 (actual)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
After endoscopic resection (ER) of gastric tumors, eradication of Helicobacter pylori (H. pylori) infection is advised to reduce metachronous recurrence. However, few studies have addressed factors influencing H. pylori eradication rates in the aftermath of ER, and none have focused on the optimal timing of therapy to eradicate H. pylori post-ER.Therefore, the investigators will conduct to evaluate whether differences in timing of eradication therapy after ER of gastric tumors.
Detailed description
Uur previous retrospective study unveiled that administering eradication treatment within 2 weeks post-ESD during the active reparative phase of ESD-induced ulcers yielded a markedly higher success rate compared to treatment post-8 weeks during the scarring phase of ESD-induced ulcers.Therefore, we conducted a multicenter, randomized, prospective study to ascertain whether the optimal timing of eradication post-ESD could influence the eradication success rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | eradication timing | patients who underwent ESD for gastric neoplasms were randomized to receive early (3-5 days) or late (8-9 weeks) H. pylori eradication therapy after ESD. |
Timeline
- Start date
- 2016-10-10
- Primary completion
- 2021-03-30
- Completion
- 2021-06-30
- First posted
- 2016-10-03
- Last updated
- 2024-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02921399. Inclusion in this directory is not an endorsement.